openPR Logo
Press release

Investigation announced for Investors in shares of Laboratory Corporation of America Holdings (NYSE: LH)

01-26-2022 05:19 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Laboratory Corporation of America Holdings (NYSE: LH) shares.

An investigation for investors in Laboratory Corporation of America Holdings (NYSE: LH) shares.

An investigation was announced concerning potential securities laws violations by Laboratory Corporation of America Holdings in connection with certain financial statements.

Investors who purchased shares of Laboratory Corporation of America Holdings (NYSE: LH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by Laboratory Corporation of America Holdings regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Burlington, NC based Laboratory Corporation of America Holdings is an independent clinical laboratory company that offers various tests, including blood chemistry analyses, urinalyses, and blood cell counts. Specifically, Laboratory Corporation of America Holdings’s products include a prenatal blood test that purportedly detects developmental problems in the DNA of a fetus with remarkable accuracy.
On January 1, 2022, The New York Times published an article questioning the accuracy of Laboratory Corporation of America Holdings’s prenatal blood tests. Specifically, the article indicated, among other things, that the positive results of the prenatal blood tests offered by Labcorp are “incorrect about 85 percent of the time.” Additionally, the article revealed that “patients who receive a positive result are supposed to pursue follow-up testing,” but that such tests “can cost thousands of dollars, come with a small risk of miscarriage and can’t be performed until later in pregnancy.”

Shares of Laboratory Corporation of America Holdings (NYSE: LH) declined from $313.04 per share on December 16, 2021, to as low as $264.22 per share on January 24, 2022.

Those who purchased shares of Laboratory Corporation of America Holdings (NYSE: LH) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in shares of Laboratory Corporation of America Holdings (NYSE: LH) here

News-ID: 2538338 • Views: 258

More Releases from Shareholders Foundation

Investigation announced for Investors in shares of Graphite Bio, Inc. (NASDAQ: G …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Graphite Bio, Inc. Investors who purchased shares of Graphite Bio, Inc. (NASDAQ: GRPH) and currently hold any of those NASDAQ: GRPH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Graphite Bio, Inc. directors breached their fiduciary duties and caused
Romeo Power, Inc. (NYSE: RMO) Investor Notice: Update in Lawsuit against Romeo P …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Romeo Power, Inc. (NYSE: RMO). Investors who are current long term investors in Romeo Power, Inc. (NYSE: RMO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On April 16, 2021, a lawsuit was filed against Romeo Power, Inc. over alleged securities laws violations.
Investigation announced for Long-Term Investors in Standard Lithium Ltd. (NYSE: …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Standard Lithium Ltd. Investors who are current long-term investors in Standard Lithium Ltd. (NYSE: SLI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long-term investors in NYSE: SLI stocks follows a lawsuit filed against Standard Lithium Ltd. over
Match Group, Inc. (NASDAQ: MTCH) Shareholder Notice: Update in Lawsuit against M …
The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in Match Group, Inc. (NASDAQ: MTCH). Investors who purchased shares of Match Group, Inc. (NASDAQ: MTCH) and currently hold any of those NASDAQ: MTCH shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On October 3, 2019, a lawsuit was filed against Match Group Inc over alleged

All 5 Releases


More Releases for Laboratory

Laboratory Glass Container market
The global Laboratory Glass Container market is likely to experience dynamic growth in the forthcoming years as a result of rapid innovations and technological advancements, along with speedy globalization. The Laboratory Glass Container market size is forecasted to reach the Highest Revenue by 2026. According to a report published by Fortune Business Insights, titled “Laboratory Glass Container market size, share & industry analysis, By Type (Dish, Bottle, Flask, Pipette, Burette,
Laboratory Information Management System
The Laboratory Information Management System (LIMS) is part of a laboratory system that helps consolidate laboratory work, such as consolidating test results and speeding up the overall work performed in the laboratory. Laboratory Information Management System (LIMS) software helps you effectively manage samples and data related to this. Key features include data tracking support, a flexible architecture and a data exchange interface that fully supports use in regulated environments. With the
Pathology and Laboratory medicine conferences
We take this opportunity to express our gratitude for institutes like you to participate in the event "16th Global Experts Meeting on Pathology and Laboratory Medicine" at Osaka, Japan during March 28-29, 2019 and making it a success. Once again, the time has come when we start to organize the "Pathology summit 2019" this year. This year we are inviting eminent dignitaries to make the event more interesting. It gives us
Is Your Laboratory Smart?
Today’s laboratories are moving beyond point automation solutions, such as LIMS, ELNs, and robot-based HTS systems, to create “smart environments” that not only embrace the comfort and convenience needs of lab technicians but also help improve the consistency and reproducibility of experimental results. If you asked laboratory professionals 15 years ago to describe their ideal modern “smart” laboratory, they would have mentioned some of the then cutting-edge data collection and automation
The Institute of Biomedical Laboratory Science-Laboratory Medicine
The Institute of Biomedical Laboratory Science-Laboratory Medicine (IBMLS) is a member organisation for Biomedical Laboratory Scientists in the EU/UK and worldwide. It strives to promote and advance the role of Biomedical Laboratory Science within the healthcare setting to deliver a high quality laboratory service for patients. Biomedical Laboratory Science Online Education (BMLSE) IBMLS provides currently Continuing Professional Development (CPD) education for members through Biomedical Laboratory Science Online Education. This programme includes 30
Laboratory accreditation imperative for strengthening laboratory systems in Nige …
One of the highly anticipated topics at Medic West Africa is the issue of laboratory accreditation and its importance in strengthening laboratory systems in Nigeria. Air Commodore, Commanding Officer, 445 Nigerian Air Force Laboratory, Dr Edward Abayomi Akinwale will be speaking about this topic during the MEDLAB laboratory conference. The 2nd edition of Medic West Africa will be held from 16 - 18 October 2013 at the Eko Hotel &